Hasan Mahmud, PhD
About Hasan Mahmud, PhD
Hasan Mahmud, PhD, is a Senior Scientist specializing in Immunotherapy at ElevateBio, where he focuses on enhancing T cell fitness for cancer treatments using advanced gene editing techniques. He has extensive experience in various research roles across multiple countries, contributing to the development of next-generation immunotherapies.
Work at ElevateBio
Hasan Mahmud serves as a Senior Scientist in Immunotherapy at ElevateBio since 2021. In this role, he focuses on enhancing T cell fitness through advanced gene editing techniques. He has led several Investigational New Drug (IND)-enabling studies, contributing to the development of innovative cancer treatments. His work involves optimizing T cell persistence and efficacy, which are critical for effective immunotherapy.
Education and Expertise
Hasan Mahmud holds a Doctor of Philosophy (PhD) in Physiology and Medical Biology from the University of Tübingen, which he completed from 2006 to 2009. He also earned a Master of Science in Biochemistry and Molecular Biology from Rajshahi University, Bangladesh, from 2004 to 2006. His educational background provides a strong foundation for his expertise in advanced gene editing, multi-color Flow Cytometry, and multiplex ELISA techniques.
Background
Hasan Mahmud has an extensive academic and professional background in immunotherapy and molecular biology. He began his studies at Rajshahi University, where he completed his Bachelor of Science degree from 1999 to 2004. He has worked in various prestigious institutions, including the University of Groningen and University Medical Center Groningen in the Netherlands, and the Stephenson Cancer Center in the USA.
Previous Positions
Before joining ElevateBio, Hasan Mahmud held several significant positions. He worked as a Senior Research Scientist at the University of Groningen from 2013 to 2017 and as a CAR-T R&D Scientist at Miltenyi Biotec from 2019 to 2021. Additionally, he served as a Postdoctoral Fellow at University Medical Center Groningen from 2009 to 2013 and as a Graduate Student at the University of Tübingen from 2006 to 2009.
Research Contributions
Hasan Mahmud has made notable contributions to the field of immunotherapy, particularly in engineered T-cell expansion and the optimization of Lenti Viral Vectors. His experience includes developing next-generation immunotherapies and utilizing complex assays to evaluate TCR and CAR T functions, which are essential for advancing cancer treatment methodologies.